Lightheart Charmaine

EVP/CRDEO Lightheart Charmaine buys 325 RVSB shares at $5.36; modest $1.7K purchase expands holdings 2.2%

Lightheart Charmaine, EVP/Chief Risk and Development Executive Officer, purchased 325 shares at $5.36 on 2026-03-05 for $1,742.00, expanding her holdings from 14,568 to 14,893 shares (+2.2%). The stock currently trades at $5.36, down 16.2% from its 52-week high of $6.40. Her prior four purchases at RVSB showed mixed timing: one delivered +12.6% over 90 days (buy on 2025-08-07), but the other three posted negative 90-day returns (-7.5%, -6.8%, -8.4%), with only 1 of 4 prior buys proving well-timed at the 90-day mark. The modest transaction size and her uneven track record at this ticker suggest routine portfolio activity rather than a concentrated conviction signal.

EVP/CRDEO Lightheart Charmaine buys 508 shares at $4.92; stock down 23.1% from 52-week high, cluster activity detected.

Lightheart Charmaine, EVP/CRDEO, purchased 508 shares at $4.92 on 2025-08-07 amid significant price weakness: the stock is trading 23.1% below its 52-week high and down 20.0% over the past 90 days. Her holdings increased from 6,972 to 7,480 shares, a +7.3% addition. A cluster buy signal is present, with 2 other insiders also purchasing within the past 14 days, suggesting broader internal confidence. However, the insider's same-ticker history at RVSB shows mixed execution: prior June purchases recorded 30-day gains of +5.1% and +5.9%, but an earlier May buy posted a -1.4% 30-day return. None of her 3 prior RVSB trades yet have measurable 90-day outcomes to assess forward-looking accuracy.

EVP/CRDEO Lightheart Charmaine buys 498 shares totaling $2,712.57 at RIVERVIEW BANCORP; cluster pattern signals coordinated action

Lightheart Charmaine, EVP/CRDEO at Riverview Bancorp, executed 3 separate purchases totaling 498 shares for $2,712.57 over four trading days (May 30 through June 3), at prices ranging from $5.43 to $5.58, representing a 7.7% increase in her holding to 6,972 shares post-transaction. The timing aligns with significant downward price momentum: the stock has declined 15.4% over the past 30 days and sits 15.6% below its 52-week high of $6.40, though it remains 5.3% above its 90-day baseline. The CLUSTER section notes 2 other insiders also bought within the past 14 days, indicating a pattern of coordinated accumulation among company leadership. This multi-insider buying activity during a period of price weakness, combined with the company's elevated valuation metrics (P/E of 135.00 on net income of $1,232,000.00), warrants investor attention to understand whether this reflects confidence in near-term recovery or represents routine portfolio management activity.